India, often called the "Pharmacy of the World," supplies over 20% of the global market for generic medicines and exports pharmaceutical products to more than 200 countries. However, for international…
The Indian pharmaceutical sector is undergoing a significant transformation in 2026, driven by landmark regulatory reforms from the Central Drugs Standard Control Organization (CDSCO), new clinical trial fast-track rules, updated…
India, known as the "Pharmacy of the World," supplies over 20% of the global generic medicine market by volume. But with this position comes a critical responsibility — maintaining rigorous…
The United States Food and Drug Administration (USFDA) has approached Indian pharmaceutical manufacturers to address a critical shortage of ifosfamide, a chemotherapy drug essential for treating testicular cancer, lung cancer,…